SpectraGenetics collaborates with CMU (Carnegie Mellon University) to developed technology to find new cancer therapeutics targeting GPCRs.
Posted by admin on Oct 3, 2022 in News | 0 comments
SpectraGenetics collaborates with CMU (Carnegie Mellon University) to developed technology to find new cancer therapeutics targeting GPCRs.